Have a personal or library account? Click to login
What about microparticles? Perspectives and practical aspects Cover

What about microparticles? Perspectives and practical aspects

Open Access
|Aug 2013

References

  1. 1. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest. 2004;34:392-401
  2. 2. Boilard E, Nigrovic PA, Larabee K, Watts GFM, Coblyn JS, Weinblatt ME, et al. Platelets amplify inflammation in arthritis via collagen dependent microparticle production. Science. 2010; 327(5965): 580-310.1126/science.1181928292786120110505
  3. 3. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9:581-9310.1038/nri256719498381
  4. 4. del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005; 106:1604-1110.1182/blood-2004-03-109515741221
  5. 5. Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry. 2010; 77A (6):502-1410.1002/cyto.a.20886291989420235276
  6. 6. Nieuwland R, Sturk A. Why do cells release vesicles?. Thromb Res. 2010 Feb; 125: S49-5110.1016/j.thromres.2010.01.03720149923
  7. 7. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008; 3:e369410.1371/journal.pone.0003694257789119002258
  8. 8. Jonas R, Nilsson A, Balaj L, Hulleman E, van Rijn S, Pegtel DM, et al. Blood platelets contain tumor-derived RNA biomarkers. Blood. 2011; 118: 3680-310.1182/blood-2011-03-344408722463721832279
  9. 9. van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 2012; 64(3): 676-70510.1124/pr.112.00598322722893
  10. 10. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010; 8:2358-6810.1111/j.1538-7836.2010.04007.x20695980
  11. 11. Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood. 2008; 111: 5028-3610.1182/blood-2007-06-097410238413118198347
  12. 12. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20:1-2610.1016/j.tmrv.2005.08.001
  13. 13. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q, et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood. 2009; 114: 723-3210.1182/blood-2009-02-205930
  14. 14. Al-Nedawi K, Meehan B, Rak J. Microvesicles: messengers and mediators of tumor progression. Cell Cycle. 2009; 8: 2014-1810.4161/cc.8.13.8988
  15. 15. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell derived microparticles in haemostasis and vascular medicine. Thromb Haemost. 2009; 101:439-5110.1160/TH08-08-0521
  16. 16. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967; 13: 269-8810.1111/j.1365-2141.1967.tb08741.x
  17. 17. Horstman LL, Ahn YS. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999; 30: 111-4210.1016/S1040-8428(98)00044-4
  18. 18. Dignat George F. Microparticles in vascular diseases. Thromb Res 2008; 122; Suppl 1, S55-910.1016/S0049-3848(08)70020-3
  19. 19. Ye R, Ye C, Huang Y, Liu L, Wang S. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. 2012; 130:253-8
  20. 20. Freyssinet JM, Toti F. Formation of procoagulant microparticles and properties. Thromb Res. 2010;125(Suppl 1): S46-810.1016/j.thromres.2010.01.036
  21. 21. Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol. 2010; 26(4): e140-e14510.1016/S0828-282X(10)70371-8
  22. 22. Flaumenhaft R, Dilks JR, Richardson, Alden E, Patel-Hett SR, Battinelli E, et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood. 2009; 113:1112-2110.1182/blood-2008-06-163832263507618802008
  23. 23. Dasgupta SK, Le A, Chavakis, Rumbaut RE, Thiagarajan P. Developmental Endothelial Locus-1 (Del-1) mediates clearance of platelet microparticles by the Endothelium. Circulation. 2012; 125 (13): 1664-7210.1161/CIRCULATIONAHA.111.068833
  24. 24. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost. 2010; 8(11):2358-6810.1111/j.1538-7836.2010.04007.x
  25. 25. Falanga A, Tartari CJ, Marchetti M. Microparticles in tumor progression. Thromb Res 2012; 129; Suppl 1, S132-610.1016/S0049-3848(12)70033-6
  26. 26. Rak J. Microparticles in cancer. Semin Thromb Hemost. 2010; 36:888-90610.1055/s-0030-1267043
  27. 27. Varon D, Hayon Y, Dashevsky O, Shai E. Involvment of platelet derived microparticles in tumor metastasis and tissue regeneration. Thromb Res 2012; 130: S98-910.1016/j.thromres.2012.08.289
  28. 28. Castaman G, Yu-Feng L, Rodeghiero F. A bleeding disorder characterized by isolated deficiency of platelet microvesicle generation. Lancet 1996; 347:700-110.1016/S0140-6736(96)91259-3
  29. 29. Castaman G, Yu-Feng L, Battistin E. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol 1997; 96:458-6310.1046/j.1365-2141.1997.d01-2072.x9054648
  30. 30. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004; 1636:119-2810.1016/j.bbalip.2003.07.00315164759
  31. 31. Ahn YS. Cell-derived microparticles:‘Miniature envoys with many faces’. J Thromb Hemost 2005; 3:884-710.1111/j.1538-7836.2005.01347.x15869581
  32. 32. Rank A, Nieuwland R, Delker R, Kohler A, Toth B, Pihusch V, et al. Cellular origin of platelet-derived microparticles in vivo. Thromb Res. 2010; 126: e255-e25910.1016/j.thromres.2010.07.01220696467
  33. 33. Lechner D, Weltermann A. Circulating tissue factorexposing microparticles. Thromb Res. 2008; 122 (Suppl.1):S47-5410.1016/S0049-3848(08)70019-7
  34. 34. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97(3):425-3410.1160/TH06-06-0313
  35. 35. Jy W, Horstman LL, Jimenez JJ, Ahn YS, Biró E, Nieuwland R, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2:1842-310.1111/j.1538-7836.2004.00936.x
  36. 36. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol. 2007 Dec; 7(12):964-7410.1038/nri2214
  37. 37. Castellana D, Totti F, Freyssinet JM. Membrane microvesicles: macromessengers in cancer disease and progression. Thromb Res. 2010; 125 (Suppl 2):S84-810.1016/S0049-3848(10)70021-9
  38. 38. Campello E, Spiezia L, Radu CM, Bulato C, Castelli M, Gavasso S, et al. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res. 2011; 127(5):473-710.1016/j.thromres.2011.01.002
  39. 39. Basavaraj MG, Olsen JO, Osterud B, Hansen JB. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Thromb Res. 2012; 130:538-14 10.1016/j.thromres.2012.06.001
  40. 40. Key NS. Analysis of tissue factor positive microparticles. Thromb Res. 2010; 125:S42-510.1016/j.thromres.2010.01.035
  41. 41. Ruf W. Tissue factor and cancer. Thromb Res. 2012; S84-710.1016/j.thromres.2012.08.285
  42. 42. Zwicker JI. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb Res.2010; 125(Suppl.2):S89-9110.1016/S0049-3848(10)70022-0
  43. 43. Chitlur M, Massicotte MP. The perfect measure of hemostasis: a quest for the holy grail. Thromb Res. 2010; 125(6): 481-210.1016/j.thromres.2009.08.022
  44. 44. Favaloroa EJ, Lippi G. Coagulation update: what’s new in hemostasis testing? Thromb Res. 2011; 127; Suppl. 2 :S13-S610.1016/S0049-3848(10)70148-1
  45. 45. Siljander PRM. Platelet-derived microparticles - an updated perspective. Thromb Res. 2011; 127:S30-310.1016/S0049-3848(10)70152-3
  46. 46. Lawrie AS, Albanyan A, Cardigan RA, Mackie IJ, Harrison P. Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang.2009; 96(3):206-1210.1111/j.1423-0410.2008.01151.x19175566
  47. 47. Yuana Y, Oosterkamp TH, Bahatyrova S...Atomic force microscopy: a novel approach to the detection of nano-sized blood microparticles. J Thromb Haemost. 2010; 8(2):315-2310.1111/j.1538-7836.2009.03654.x19840362
  48. 48. Gross PL, Vaezzadeh N. Tissue factor microparticles and haemophilia. Thromb Res.2010; 125:S67-910.1016/j.thromres.2010.01.04120171716
  49. 49. Dignat-George F, Feyssinet JM, Key NS. Centrifugation is a crucial step impacting microparticle measurement. Platelets. 2009 ; 20(3):225-610.1080/0953710090279550019437341
  50. 50. Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, et al. Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thromb Res 2011; 127:370-710.1016/j.thromres.2010.12.01421257195
  51. 51. Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012; 10:437-4610.1111/j.1538-7836.2011.04610.x22212198
  52. 52. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost. 2009; 7(1):190-7
  53. 53. Trummer A, De Rop C, Tiede A, Ganser A, Eisert R. Isotype controls in phenotyping and quantification of microparticles: A major source of error and how to evade it. Thromb Res 2008; 122:691-70010.1016/j.thromres.2008.01.00518304614
  54. 54. György B, Módos K, Pállinger E, Pálóczi K, Pásztói M, Misják P et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood. 2011; 117(4):e39-4810.1182/blood-2010-09-30759521041717
  55. 55. Williams JC, Mackman N. MPs or ICs? Blood. 2011; 117: 1101-2
  56. 56. Mobarrez F, Antovic J, Egberg N, Hansson M, Jorneskog G, Hultenby K et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 2010; 125:e110-610.1016/j.thromres.2009.10.00619939440
  57. 57. Hind E, Heugh S, Ansa-Addo EA, Antwi-Baffour S, Lange S, Inal J. Red cell PMVs, plasma membrane-derived vesicles calling out for standards. Biochem Biophys Res Commun 2010; 399: 465-9 10.1016/j.bbrc.2010.07.09520674549
DOI: https://doi.org/10.2478/rrlm-2013-0013 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 9 - 15
Published on: Aug 8, 2013
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Andra Costache, Simona I. Avram, Alina Cernucan, Doina Barbu, Silvana Angelescu, Delia Mut Popescu, Anca R. Lupu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.